Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma.
about
Improving radiotherapy in cancer treatment: Promises and challenges.Exome sequencing reveals aberrant signalling pathways as hallmark of treatment-naive anal squamous cell carcinoma.Evaluation of Prexasertib, a Checkpoint Kinase 1 Inhibitor, in a Phase Ib Study of Patients with Squamous Cell Carcinoma.
P2860
Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma.
@en
Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma.
@nl
type
label
Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma.
@en
Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma.
@nl
prefLabel
Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma.
@en
Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma.
@nl
P2093
P2860
P1476
Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma.
@en
P2093
Alan D D'Andrea
Alexis Damish
Ali Amin-Mansour
Brendan Reardon
Diana Miao
Eliezer M Van Allen
Harvey J Mamon
Jaegil Kim
James M Cleary
Jason L Hornick
P2860
P304
P356
10.1158/1078-0432.CCR-16-2017
P407
P577
2016-11-16T00:00:00Z